~ archived since 2018 ~

Recent testosterone drop-off and risk of cardiovascular events

UnHope20

December 28, 2021

5 upvotes

/r/Male_Studies

Archived from /r/Male_Studies

r/Male_Studies is a place to post and discuss research, data or surveys about males. Anti-male content NOT allowed.

TheRedArchive is an archive of Red Pill subreddits and blogs. This page is our copy of the original post.

/r/Male_Studies archive

Download the post

Want to save the post for offline use on your device? Choose one of the download options below:

PDF TXT EPUB

Support the archive

Everything here was supposed to disappear. Banned subreddits, deleted communities, cancelled blogs — much of what is archived here survives nowhere else.

It stays free — no paywall, no account — for the next man who comes looking, the way it was free for you.

I pay for the servers, the storage and the bandwidth myself. If you want this record still standing in ten years, become one of the people who keeps it online.

Support the archive

Post Information

Title	Recent testosterone drop-off and risk of cardiovascular events
Author	UnHope20
Upvotes	5
Comments	1
Date	December 28, 2021 1:06 AM UTC (4 years ago)
Subreddit	Posted in /r/Male_Studies
Original Link	https://old.reddit.com/r/Male_Studies/comments/rq2iwp/recent_testosterone_dropoff_and_risk_of/
Archive Link	https://theredarchive.com/r/Male_Studies/recent-testosterone-drop-off-and-risk-of.1216083 https://theredarchive.com/post/1216083

Comments

[–]UnHope20[S] 2 points3 points4 points 4 years ago (0 children) | Copy Link

Low baseline testosterone level has been associated with the development of risk factors for cardiovascular disease such as insulin resistance and obesity. In addition to the absolute testosterone level, remarkable changes in testosterone level may have an acute effect on cardiovascular disease development and progression, which has been rarely investigated.

In this study, we used a clinical dataset of 376 hypogonadal men whose testosterone levels were measured every six months for up to 11 years from a registry study in Germany, and conducted survival analyses to investigate the effect of testosterone changes since the last visit (time-varying) on the risk of cardiovascular events.

Given the potential discrepancies in comorbidity conditions among patients with prior cardiovascular events and those without, all the analyses were stratified by patients’ prior cardiovascular event status.

We found the effects were not different among patients with prior cardiovascular events and those without. Regardless of patients’ prior cardiovascular event status, patients with larger testosterone declines (≥3.12 nmol/L, 90th percentile) since the last visit were more likely to experience myocardial infarction.

In conclusion, recent pronounced testosterone drop-offs may affect the risk of cardiovascular events among hypogonadal men. Future longitudinal studies are needed to confirm our exploratory study findings.